Kuala Lumpur - Delayed Quote MYR

UEM Edgenta Berhad (1368.KL)

0.7450

0.0000

(0.00%)

At close: 4:59:02 PM GMT+8

How tariffs impact pharma stocks

Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior pharma & biotech analyst Tim Anderson describes how tariffs will impact the pharmaceutical stocks he covers. He also explains why Eli Lilly (LLY) and Novo Nordisk (NVO) have a "moat" around them. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 1 hour ago

LLY

NONOF

NVO
Tesla stock surges 9.8%, clinches 18% weekly gain after DoT unveils new self-driving car rules

Tesla stock jumped on Friday to cap off a positive week for the company.

Yahoo Finance 3 hours ago

TSLA
Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss

As part of today's Market Minute, Julie Hyman examines some of the top stories investors are watching. Bitcoin (BTC-USD) climbs above the $95,000 mark as investors weigh macroeconomic uncertainties. AbbVie (ABBV) stock gains after reporting strong first quarter results and lifting its 2025 profit forecast. Phillips 66 (PSX) shares fall after announcing a wider-than-expected loss in the first quarter. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 6 hours ago

ABBV

PSX

BTC-USD
Why Amazon, Spotify, & Netflix are this expert's top stock picks

Market volatility has emerged as a major theme for investors. Laffer Tengler Investments CEO and CIO Nancy Tengler joins Morning Brief with Madison Mills and Brad Smith to share some of her top stock picks, including Amazon (AMZN), Spotify (SPOT), and Netflix (NFLX). To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 9 hours ago

NFLX

AMZN

SPOT
AbbVie, Schlumberger, Colgate-Palmolive: Trending tickers

Here are some stocks on the move on April 25. AbbVie (ABBV) raised its 2025 profit forecast, citing the strength of some of the newer drugs in its immunology portfolio. Schlumberger (SLB) reported first quarter earnings that fell short of estimates. Colgate-Palmolive (CL) cut its full-year earnings outlook, citing tariff impacts. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 9 hours ago

CL

ABBV

SLB
Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors

Investing.com – Galloway Capital Partners is urging WW International Inc (NASDAQ:WW) to avoid Chapter 11 bankruptcy, after disclosing a 2.87% stake in the embattled weight management company. The firm’s Chief Investment Officer, Bruce Galloway, told Investing.com that Weight Watchers still has solid fundamentals and does not meet the criteria for insolvency, making a bankruptcy filing both unwarranted and damaging to equity holders.

Investing.com 29 minutes ago

WW

RGS
Jim Cramer Reacts to Tesla (TSLA) Rally: “Musk Is Back, That’s Enough”

We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against other stocks that Jim Cramer discussed. On Wednesday, Jim Cramer, the host of Mad Money, took to discussing how President Donald Trump’s influence […]

Insider Monkey 1 hour ago

TSLA
S&P 500 Gains and Losses Today: Charter Communications Soars as Subscriber Growth Impresses

The S&P 500 added 0.7% on Friday, April 25, 2025, as China reportedly considered suspending tariffs on some U.S. goods, and tech stocks extended their rally.

Investopedia 2 hours ago

^GSPC

CHTR

TMUS
Why AbbVie Stock Topped the Market Today

A pair of convincing quarterly earnings beats -- not to mention a profitability guidance raise -- made AbbVie (NYSE: ABBV) stock an investor darling on Friday. The pharmaceutical company's performance pushed its stock to a more than 3% gain on the day, well higher than the 0.6% bump of the bellwether S&P 500 index it's a part of. For its first quarter of this year, AbbVie's net revenue was $13.3 billion, representing a sturdy 8% improvement on a year-over-year basis.

Motley Fool 2 hours ago

ABBV
Tesla Begins Refunding Early India Model 3 Bookings Amid Expansion Plans

Tesla started refunding early India Model 3 bookings from 2016.

GuruFocus.com 2 hours ago

TSLA
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Both U.S.-based Summit Therapeutics (NASDAQ: SMMT) and BioNTech (NASDAQ: BNTX) were down significantly, plunging 36.1% and 15.4%, respectively, in Friday's trading. The severe moves were likely related to a Chinese rival in the PD-1/VEGF bispecific antibody area, Akeso (OTC: AKES.F), receiving FDA approval for a cancer drug that utilizes similar technology, as well as an additional approval in China. As a result, Akeso shares were up 11.7% on Friday.

Motley Fool 2 hours ago

SMMT

BNTX

AKESF
Tesla Shares Rise as U.S. Moves to Ease Rules on Self-Driving Cars

The Trump administration announced plans to relax regulations on self-driving vehicles.

GuruFocus.com 2 hours ago

TSLA
Tesla Stock Is a Buy for 3 Reasons, Says Analyst. Plus, Apple v. Tariffs, and More.

Analysts also weigh in on TE Connectivity, Lithia Motors, Travel + Leisure, and Check Point Software Technologies.

Barrons.com 3 hours ago

TSLA

AAPL

TEL
The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week

Elon Musk is planning more time at Tesla less time in the White House. During Tesla’s earnings call, the billionaire chief executive talked about his plans to pull back from the Department of Government Efficiency, saying that he expects to continue spending “a day or two” each week on government matters. Musk’s controversial work with the Trump administration and his political endorsements have weighed on Tesla demand and led to protests and vandalism at Tesla showrooms.

The Wall Street Journal 3 hours ago

COF

COF-PK

COF-PL
Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?

We recently published a list of the 15 Best Dividend Stocks to Buy for Long-Term Passive Income. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend stocks for long-term income. Passive income, which refers to money earned with little ongoing effort, was once largely the […]

Insider Monkey 3 hours ago

ABBV
Spotify Stock Tests Buy Point Ahead Of Q1 Report

Spotify stock has been climbing ahead of the streaming music giant's first-quarter report due next Tuesday as investors expect melodious news.

Investor's Business Daily 3 hours ago

SPOT
Is Eli Lilly and Company (LLY) the Best Stock to Invest in for Long Term?

We recently published a list of 10 Best Stocks to Invest in for Long Term. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best stocks to invest in for long term. The markets have had two monster years with the S&P 500 index […]

Insider Monkey 3 hours ago

LLY
BigBear.ai Shares Jump 11% on Friday After Announcing AI Deal With Austal USA

Shipyard AI will support Austal USA's modernization at its Mobile, Alabama, facility.

GuruFocus.com 3 hours ago

ASB.AX

BBAI-WS
Amplify Energy and Juniper Capital Announce Termination of Merger Agreement

HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify” or the “Company”) announced today that the Company and Juniper Capital Advisors, L.P. (“Juniper”) have entered into a mutual termination agreement (“Termination Agreement”) to terminate (the “Termination”) the previously announced Agreement and Plan of Merger (the “Merger Agreement”) in light of the extraordinary volatility in the market. In accordance with the terms of the Termination Agreement, Juniper is

GlobeNewswire 3 hours ago

AMPY
Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains

Saia’s shares are getting punished as the company’s ambitious growth efforts have been derailed by a trade war. The post Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains appeared first on FreightWaves.

FreightWaves 3 hours ago

SAIA

Performance Overview

Return	1368.KL	FTSE Bursa Malaysia KLCI (^KLSE)
YTD	-3.15%	-8.11%
1-Year	-13.79%	-3.83%
3-Year	-46.93%	-5.08%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

UEM Edgenta Berhad (1368.KL)

Related News

How tariffs impact pharma stocks

Tesla stock surges 9.8%, clinches 18% weekly gain after DoT unveils new self-driving car rules

Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss

Why Amazon, Spotify, & Netflix are this expert's top stock picks

AbbVie, Schlumberger, Colgate-Palmolive: Trending tickers

Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors

Jim Cramer Reacts to Tesla (TSLA) Rally: “Musk Is Back, That’s Enough”

S&P 500 Gains and Losses Today: Charter Communications Soars as Subscriber Growth Impresses

Why AbbVie Stock Topped the Market Today

Tesla Begins Refunding Early India Model 3 Bookings Amid Expansion Plans

Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Tesla Shares Rise as U.S. Moves to Ease Rules on Self-Driving Cars

Tesla Stock Is a Buy for 3 Reasons, Says Analyst. Plus, Apple v. Tariffs, and More.

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week

Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?

Spotify Stock Tests Buy Point Ahead Of Q1 Report

Is Eli Lilly and Company (LLY) the Best Stock to Invest in for Long Term?

BigBear.ai Shares Jump 11% on Friday After Announcing AI Deal With Austal USA

Amplify Energy and Juniper Capital Announce Termination of Merger Agreement

Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains

Performance Overview